Wolverine Trading
INFI

Wolverine Trading’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Wolverine Trading’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,895
Closed -$10.1K – 5350
2022
Q3 		$14K Buy
+11,895
New +$12.8K ﹤0.01% 4418
2021
Q3 		– Sell
-27,542
Closed -$86K – 7220
2021
Q2 		$86K Sell
27,542
-9,705
-26% -$30.7K ﹤0.01% 5470
2021
Q1 		$112K Buy
+37,247
New +$124K ﹤0.01% 5390
2019
Q1 		– Sell
-10,629
Closed -$13K – 5532
2018
Q4 		$13K Buy
+10,629
New +$19.1K ﹤0.01% 4302
2018
Q3 		– Sell
-13,010
Closed -$26.9K – 6142
2018
Q2 		$27K Hold
13,010
– – ﹤0.01% 5001
2018
Q1 		$27K Buy
+13,010
New +$27.9K ﹤0.01% 5001
2017
Q2 		– Sell
-12,639
Closed -$24.4K – 5165
2017
Q1 		$42K Sell
12,639
-2,245
-15% -$5.52K ﹤0.01% 4028
2016
Q4 		$20K Buy
14,884
+281
+2% +$367 ﹤0.01% 4315
2016
Q3 		$22K Sell
14,603
-654
-4% -$1K ﹤0.01% 4500
2016
Q2 		$21K Buy
+15,257
New +$71.3K ﹤0.01% 3899

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wolverine Trading's INFI Position: Q4 2022 in Review

Wolverine Trading sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2022, closing a stake of 11,895 shares — an estimated $10.1K sold.

Wolverine Trading first reported a position in INFI in Q2 2016 and held it in 10 quarters. The position peaked at $112K in Q1 2021. 68 funds tracked by Wall St. Rank hold INFI as of Q4 2022.

  • Wolverine Trading reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • Wolverine Trading sold 11,895 Infinity Pharmaceuticals, Inc. shares in Q4 2022, an estimated $10.1K.
  • Wolverine Trading first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2016 and held it in 10 quarters.
  • Wolverine Trading's Infinity Pharmaceuticals, Inc. position peaked at $112K in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2022.

Based on Wolverine Trading's 13F filing for Q4 2022, filed 14 Feb 2023.